Showing posts with label cancer. Show all posts
Showing posts with label cancer. Show all posts

Friday, September 23, 2011

UCLA study shows prostate cancer finds a way to hormone therapy by enabling a survival cell signal to bypass road:

Asbestos-exposure placement

In a study conducted at the UCLA Jonsson Comprehensive Cancer Center found androgen production or androgen receptor function treated researchers out, if not a common type of prostate cancer with conventional ablation hormone therapy block, who was cancer able adapt and balance by enabling a survival cell signal path, effectively bypass the roadblock put up by this treatment.

Mesothelioma lawyers mesothelioma news.

View the original article here

Sunday, September 18, 2011

Researchers develop UC Davis cancer patients from tool to the surgical risk in terminally ill to evaluate:

Top mesothelioma lawyers

Doctors and patients with late stage cancer now have a tool so that they decide whether surgery is the best choice.

Mesothelioma lawyers mesothelioma news.

View the original article here

Thursday, September 15, 2011

University of Chicago study shows that certain head and neck cancer patients benefit from the second round of treatment:

Asbestos fibres

A new study from the University of Chicago noted predictors that better can identify patients that benefit from a potentially toxic second course of treatment, a small but real chance for a cure in select patients with head and neck cancer offers.

Mesothelioma lawyers mesothelioma news.

View the original article here

Sunday, September 11, 2011

Duke study finds exercise longer survival after the brain cancer diagnosis associated with:

Top mesothelioma lawyers

Brain cancer patients who have life much longer than sedentary patients, researchers at the Duke Cancer Institute report.

Mesothelioma lawyers mesothelioma news.

View the original article here

Saturday, September 3, 2011

NIH study finds experimental drug benefits patients with rare type of cancer;

Top mesothelioma lawyers

An experimental drug, Cediranib, can benefit according to the results of a clinical trial with patients with rare, slow-growing cancer called alveolar soft part Sarcoma (ASPS).

Mesothelioma lawyers mesothelioma news.

View the original article here